VML HEALTH

When you have incredible clients willing to do the work that matters, lives change and people take notice. Congratulations to the Haleon team for your bravery and ongoing commitment to investing in and saving Black lives. Props to Katie Williams, Stacey Harris, Carrie Salmon and Renato Camera. Thank you for all that you do. Shout out to our amazing partners at Edelman and Grey, as well as my crew at VML for the relentless push to get this campaign out fir the world to see. Thank you Shorty Awards and the jury for understanding the assignment 🙏🏽 More on the way!

Really looking forward to seeing some great work on the Young Creatives Jury at Eurobest 2024. If you're 30 or under and love a meaningful creative challenge, register at https://lnkd.in/eE5Btk8t by 18th November. You're the future of our industry! Do it. Do it now. 💥 VML VML HEALTH Cannes Lions International Festival of Creativity

VML Health’s Gabriel Stern joined a lively panel at the MM+M Media Summit yesterday in NYC to discuss the use of Generative AI in Pharma.   Skillfully managed by Jack O'Brien, Managing Editor, MM+M, Gabi was joined by Paula Franco, US Marketing Lead, Johnson & Johnson, Aimee Turner, MBA, Director, Media Strategy & Analytics, Moon Rabbit and Sneha Vats, EVP, Revenue and Operations, Healthcasts Media.   Together they explored what’s happening in health related generative AI, what are the biggest obstacles, and where it’s going. These are our takeouts from a great session. Thanks again Jameson Fleming and Jack O'Brien from MM+M for running such an interesting panel.   Read more: https://lnkd.in/gxv6aiCz #VMLHealth #MMM #MMMMediaSummit #GenerativeAI #Healthcare #HealthcareMarketing #Pharma #PharmaMarketing 

Monsters don't just appear on Halloween. They can actually appear at any time of the year on our skin. That's why, with "The Scariest Monsters,” a graphic campaign for the University Assistance Complex of Salamanca from VML Health Spain, we want to prevent moles from becoming monsters. Read more about the work: https://lnkd.in/g2rgtaPt #VMLHealth #PharmaMarketing #Pharma #HealthcareMarketing #Healthcare #Cancer #Oncology #Melanoma

Thinking brand-first or disease-first is the wrong start-point for healthcare digital platforms. According to VML Health’s Jason Gloye, enhancing these platforms in health requires focus on two key areas: patient partnerships and experience design. Read more: https://lnkd.in/e_3NZzVz #VMLHealth #PatientGroups #Healthcare #HealthcareMarketing #Pharma #PharmaMarketing

The Team at LIA - London International Awards came to VML offices in London to present VML Health’s new LIA award for this year – a celebratory two Golds and One Silver for our beautiful film for AstraZeneca called “The Balancing Act”. It was a very proud moment – huge congratulations to our wonderful award-winning team.   Pictured in the group photo (from left to right): Christina Shaw (LIA Awards Director), Gian Tang (VML), Erika Roberts (VML), Aurora Corrado (VML), Khalid Latif (VML), Barbara Levy (LIA President and Founder), Nikki Sulentic (VML), Laurissa Levy (LIA Creative LIAisons Director). #VMLHealth #VML #LIA2024 #HealthcareMarketing #Healthcare #PharmaMarketing #Pharma

“Last month, a friend asked me the impossible question: Of course, they knew the obvious – there’s never a good time to have breast cancer. But they’d seen lots of recent headlines about advances in treatment and naturally assumed it would mean better outcomes for anyone being diagnosed today.” Claire Gillis, VML Health CEO, asks the big question about breast cancer in 2024 and outlines how communications forms part of the answer. Read more via The Drum: https://lnkd.in/gYwQZWUp #VMLHealth #BreastCancer #BreastCancerAwarenessMonth #MetastaticBreastCancer #MBC #Cancer #Oncology #HealthcareMarketing #Healthcare #PharmaMarketing #Pharma

We are witnessing an important shift in cancer communications — pharma is breathing life into cancer comms. ESMO - European Society for Medical Oncology’s flagship annual congress took place last month in Barcelona, once again laying down new markers of hope for the future of oncology. Susanne Bobadilla, PhD and a team of 15 VML Health and medical, digital strategists and client engagement experts from across the company gave PM LIVE a scoop of the top at the top trends from ESMO 2024 – find out what they mean for the future of cancer care. https://lnkd.in/g9BTsqVu #VMLHealth #HealthcareMarketing #Healthcare #PharmaMarketing #Pharma #Oncology #ESMO #MedicalScience

Is it better to have been diagnosed with breast cancer this year rather than last? Claire Gillis, VML Health CEO, asks the big question about breast cancer, focusing on medical advancements and where comms can help pick up the slack. Read more via The Drum: https://lnkd.in/gYwQZWUp #VMLHealth #BreastCancer #BreastCancerAwarenessMonth #MetastaticBreastCancer #MBC #Cancer #Oncology #HealthcareMarketing #Healthcare #PharmaMarketing #Pharma

It’s been an encouraging year for developments in metastatic breast cancer (mBC), with a host of scientific advances and new treatment options offering hope to patients. As we move beyond #MBCAwarenessDay, here are six big headlines from 2024 from Claire Gillis, Jason Gloye, Nichole Davies, Susanne Bobadilla, PhD, Sarah-Jane Barker and Alexandra Lewis. #1. Pembrolizumab followed by chemotherapy improves overall survival in patients with advanced triple-negative breast cancer. #2. Trastuzumab deruxtecan (Enhertu) offers better progression-free survival and response rates for some metastatic HER2-low and -ultralow breast cancers. #3. Abemaciclib improves progression-free survival in metastatic hormone-receptor-positive, HER2-negative breast cancer. #4. Inavolisib awarded Breakthrough Therapy Designation for PIK3CA-Mutated, HR+/HER2-negative mBC. #5. Triple combination of inavolisib, palbociclib and fulvestrant could reduce the risk of progression or death in patients with PIK3CA-mutant HR+/HER2-negative mBC. #6. Oral selective oestrogen receptor degraders (SERDs) could transform treatment of hormone receptor-positive advanced breast cancer. For a full run-down of all these developments, and many more from 2024, click here: https://lnkd.in/gJRu2jKH #VMLHealth #BreastCancerAwarenessMonth #MetastaticBreastCancer #MBC #BreastCancer #Cancer #Oncology #HealthcareMarketing #Healthcare #PharmaMarketing #Pharma